DR. HOWARD J FRANKLIN, MD
Radiology at Mohawk Dr, Southampton, PA
License number
Pennsylvania 052807L
Category
Radiology
Type
Surgery
Address
Address
161 Mohawk Dr, Southampton, PA 18954
Phone
(215) 396-1332
Personal information
See more information about HOWARD J FRANKLIN at radaris.comName
Address
Phone
85 Helen St, Eighty Four, PA 15330
161 Mohawk Dr, Richboro, PA 18954
161 Mohawk Dr, Richboro, PA 18954
7222 Beech Tree Dr #E, Elkins Park, PA 19027
221 Harrison Ave, Greensburg, PA 15601
Professional information
See more information about HOWARD J FRANKLIN at trustoria.com
Method Of Stably Treating Incontinence Using A Bulking Agent
Method Of Stably Treating Incontinence Using A Bulking Agent
US Patent:
2014004, Feb 13, 2014
Filed:
Oct 21, 2013
Appl. No.:
14/058836
Inventors:
Howard Franklin - Richboro PA, US
Assignee:
SALIX PHARMACEUTICALS, LTD. - Raleigh NC
International Classification:
A61K 31/721
US Classification:
514 59
Abstract:
The invention provides a method for treating fecal incontinence in a subject comprising administering in an appropriate subject a therapeutically effective amount of a biocompatible bulking agent to the wall of the anal canal. The biocompatible bulking agent comprises dextranomer and a pseudoplastic carrier, such as, hyaluronic acid, and is stable and effective in treating fecal incontinence for over 24 months, and up to at least 36 months or more following an initial administration.
Method Of Stably Treating Incontinence Using A Bulking Agent
Method Of Stably Treating Incontinence Using A Bulking Agent
US Patent:
2014000, Jan 2, 2014
Filed:
Mar 7, 2013
Appl. No.:
13/788401
Inventors:
Howard Franklin - Richboro PA, US
International Classification:
A61K 9/00, A61K 31/721, A61K 31/728
US Classification:
514 59
Abstract:
The invention provides a method for treating fecal incontinence in a subject comprising administering in an appropriate subject a therapeutically effective amount of a biocompatible bulking agent to the wall of the anal canal. The biocompatible bulking agent comprises dextranomer and a pseudoplastic carrier, such as, hyaluronic acid, and is stable and effective in treating fecal incontinence for over 24 months, and up to at least 36 months or more following an initial administration.